Cameroon vs Sur: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Sur
62.0%
in 2024
Cameroon rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Sur
How they compare
Cameroon currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Cameroon's figure about 1.6 times Sur's.
The two have swapped places 8 times across 14 shared years of data; in 2009 it was Cameroon ahead.
Cameroon ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Cameroon averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Cameroon | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 0.0% | 14.0% | Cameroon |
| 2010s | 59.1% | 59.6% | 0.5% | Sur |
| 2020s | 97.2% | 78.4% | 18.8% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Sur?
- Cameroon, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Sur?
- 38.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Sur?
- 14 years are reported by both, from 2009 to 2024.
- How do Cameroon and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.